Binding of equine infectious anemia virus to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein
The identification and characterization of a functional cellular receptor for equine infectious anemia virus (EIAV), designated equine lentivirus receptor-1 (ELR1), a member of the tumour necrosis factor receptor protein family, has been reported previously [Zhang, B. et al. (2005). Proc Natl Acad Sci U S A, 102 , 9918–9923]. The finding of a single receptor for EIAV is distinct from feline, simian and human immunodeficiency viruses, which typically utilize two co-receptors for infection, but is similar to avian and murine oncoviruses, which use single receptors. This study sought to determine ELR1-binding domains of EIAV gp90. Towards this goal, a GFP-tagged gp90 fusion protein (gp90GFP) expression vector was constructed and a specific cell–cell binding assay was developed to measure EIAV gp90 binding to ELR1. Using these assays, the receptor-binding properties of 41 gp90GFP mutants were evaluated, each with a sequential replacement 11 aa linear epitope peptide from the vesicular stomatitis virus glycoprotein (VSV-G tag), as well as eight mutants containing individual gp90 variable-domain deletions. The results of these studies demonstrated that, in general, gp90 constructs containing substitutions or deletions in the N-terminal third of gp90 retained their receptor-binding activity. In contrast, segment substitutions or deletions in the C-terminal two-thirds of gp90 eliminated receptor-binding activity. Thus, these results reveal for the first time that the ELR1-binding domains of EIAV gp90 are located in the C-terminal two-thirds of EIAV gp90, apparently as a complex of discontinuous determinants.
AdkinsH. B.,
BrojatschJ.,
NaughtonJ.,
RollsM. M.,
PesolaJ. M.,
YoungJ. A.1997; Identification of a cellular receptor for subgroup E avian leukosis virus. Proc Natl Acad Sci U S A 94:11617–11622[CrossRef]
AdkinsH. B.,
BrojatschJ.,
YoungJ. A.2000; Identification and characterization of a shared TNFR-related receptor for subgroup B, D, and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry. J Virol 74:3572–3578[CrossRef]
BallJ. M.,
RushlowK. E.,
IsselC. J.,
MontelaroR. C.1992; Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J Virol 66:732–742
BattiniJ. L.,
HeardJ. M.,
DanosO.1992; Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol 66:1468–1475
BattiniJ. L.,
DanosO.,
HeardJ. M.1998; Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol 72:428–435
BrojatschJ.,
NaughtonJ.,
RollsM. M.,
ZinglerK.,
YoungJ. A.1996; CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87:845–855[CrossRef]
ChiangH. Y.,
CohenG. H.,
EisenbergR. J.1994; Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol 68:2529–2543
ConnollyS. A.,
LandsburgD. J.,
CarfiA.,
WileyD. C.,
CohenG. H.,
EisenbergR. J.2003; Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J Virol 77:8127–8140[CrossRef]
CordonnierA.,
RiviereY.,
MontagnierL.,
EmermanM.1989; Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J Virol 63:4464–4468
de ParsevalA.,
ChatterjiU.,
SunP.,
ElderJ. H.2004; Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A 101:13044–13049[CrossRef]
EidenM. V.,
FarrellK.,
WarsoweJ.,
MahanL. C.,
WilsonC. A.1993; Characterization of a naturally occurring ecotropic receptor that does not facilitate entry of all ecotropic murine retroviruses. J Virol 67:4056–4061
FassD.,
DaveyR. A.,
HamsonC. A.,
KimP. S.,
CunninghamJ. M.,
BergerJ. M.1997; Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 Å resolution. Science 277:1662–1666[CrossRef]
GallaherW. R.,
BallJ. M.,
GarryR. F.,
GriffinM. C.,
MontelaroR. C.1989; A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 5:431–440[CrossRef]
GallaherW. R.,
BallJ. M.,
GarryR. F.,
Martin-AmedeeA. M.,
MontelaroR. C.1995; A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 11:191–202[CrossRef]
HeardJ. M.,
DanosO.1991; An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J Virol 65:4026–4032
HussainK. A.,
IsselC. J.,
SchnorrK. L.,
RwamboP. M.,
MontelaroR. C.1987; Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J Virol 61:2956–2961
HussainK. A.,
IsselC. J.,
SchnorrK. L.,
RwamboP. M.,
WestM.,
MontelaroR. C.1988; Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Arch Virol 98:213–224[CrossRef]
KreisT. E.1986; Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface. EMBO J 5:931–941
KwongP. D.,
WyattR.,
RobinsonJ.,
SweetR. W.,
SodroskiJ.,
HendricksonW. A.1998; Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648–659[CrossRef]
LeonardC. K.,
SpellmanM. W.,
RiddleL.,
HarrisR. J.,
ThomasJ. N.,
GregoryT. J.1990; Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265:10373–10382
ModrowS.,
HahnB. H.,
ShawG. M.,
GalloR. C.,
Wong-StaalF.,
WolfH.1987; Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol 61:570–578
MooreJ. P.,
SattentauQ. J.,
WyattR.,
SodroskiJ.1994; Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol 68:469–484
MorganR. A.,
NussbaumO.,
MuenchauD. D.,
ShuL.,
CoutureL.,
AndersonW. F.1993; Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol 67:4712–4721
RizzutoC. D.,
WyattR.,
Hernandez-RamosN.,
SunY.,
KwongP. D.,
HendricksonW. A.,
SodroskiJ.1998; A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949–1953[CrossRef]
RoseJ. K.,
GallioneC. J.1981; Nucleotide sequences of the mRNAs encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol 39:519–528
ShimojimaM.,
MiyazawaT.,
IkedaY.,
McMonagleE. L.,
HainingH.,
AkashiH.,
TakeuchiY.,
HosieM. J.,
WillettB. J.2004; Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303:1192–1195[CrossRef]
SuphaphiphatP.,
ThitithanyanontA.,
Paca-UccaralertkunS.,
EssexM.,
LeeT. H.2003; Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization. J Virol 77:3832–3837[CrossRef]
SuphaphiphatP.,
EssexM.,
LeeT. H.2007; Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor. Virology 360:182–190[CrossRef]
WyattR.,
MooreJ.,
AccolaM.,
DesjardinE.,
RobinsonJ.,
SodroskiJ.1995; Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 69:5723–5733
WyattR.,
KwongP. D.,
DesjardinsE.,
SweetR. W.,
RobinsonJ.,
HendricksonW. A.,
SodroskiJ. G.1998; The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705–711[CrossRef]
ZhangB.,
JinS.,
JinJ.,
LiF.,
MontelaroR. C.2005; A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. Proc Natl Acad Sci U S A 102:9918–9923[CrossRef]
ZhengY. H.,
NakayaT.,
SentsuiH.,
KameokaM.,
KishiM.,
HagiwaraK.,
TakahashiH.,
KonoY.,
IkutaK.1997; Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse. J Gen Virol 78:807–820
Binding of equine infectious anemia virus to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein